Cargando…
On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine
Mass COVID-19 vaccination, as the last resort to bring society to a new normal, has been rapidly rolled out in the US. However, because of the lifting of international travel restrictions, amid the many uncertainties induced by the emerging B.1.1.529 variant, it remains unclear about the timeline of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668343/ https://www.ncbi.nlm.nih.gov/pubmed/34922789 http://dx.doi.org/10.1016/j.vaccine.2021.11.096 |
_version_ | 1784614551526834176 |
---|---|
author | Chen, Xiang Wang, Hui |
author_facet | Chen, Xiang Wang, Hui |
author_sort | Chen, Xiang |
collection | PubMed |
description | Mass COVID-19 vaccination, as the last resort to bring society to a new normal, has been rapidly rolled out in the US. However, because of the lifting of international travel restrictions, amid the many uncertainties induced by the emerging B.1.1.529 variant, it remains unclear about the timeline of reaching herd immunity and when our daily life will return to normalcy. Since access to a vaccine is an important predicate to the achievement of herd immunity, we articulate the vaccine access issue as the degree of fit between patients and the healthcare system in five dimensions: availability, accessibility, accommodation, affordability, and acceptability. These five dimensions can be adopted in existing health practice and policy to elucidate effective strategies for raising COVID-19 vaccination rates and improving vaccine equity in the fight against the new variant. |
format | Online Article Text |
id | pubmed-8668343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86683432021-12-14 On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine Chen, Xiang Wang, Hui Vaccine Commentary Mass COVID-19 vaccination, as the last resort to bring society to a new normal, has been rapidly rolled out in the US. However, because of the lifting of international travel restrictions, amid the many uncertainties induced by the emerging B.1.1.529 variant, it remains unclear about the timeline of reaching herd immunity and when our daily life will return to normalcy. Since access to a vaccine is an important predicate to the achievement of herd immunity, we articulate the vaccine access issue as the degree of fit between patients and the healthcare system in five dimensions: availability, accessibility, accommodation, affordability, and acceptability. These five dimensions can be adopted in existing health practice and policy to elucidate effective strategies for raising COVID-19 vaccination rates and improving vaccine equity in the fight against the new variant. Elsevier Ltd. 2022-01-24 2021-12-14 /pmc/articles/PMC8668343/ /pubmed/34922789 http://dx.doi.org/10.1016/j.vaccine.2021.11.096 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Chen, Xiang Wang, Hui On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine |
title | On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine |
title_full | On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine |
title_fullStr | On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine |
title_full_unstemmed | On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine |
title_short | On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine |
title_sort | on the rise of the new b.1.1.529 variant: five dimensions of access to a covid-19 vaccine |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668343/ https://www.ncbi.nlm.nih.gov/pubmed/34922789 http://dx.doi.org/10.1016/j.vaccine.2021.11.096 |
work_keys_str_mv | AT chenxiang ontheriseofthenewb11529variantfivedimensionsofaccesstoacovid19vaccine AT wanghui ontheriseofthenewb11529variantfivedimensionsofaccesstoacovid19vaccine |